Michael Casia

Born and raised in Montreal, Michael Casia is a proud husband and father of two. He has been the President and Managing Director of Organon Canada since its launch in June 2021. Under his leadership, the Canadian team has focused on improving the health and well-being of women in Canada and strengthening the Canadian healthcare system through cost-saving solutions from its broad biosimilar portfolio.

Michael is an advocate for the adoption of biosimilars and currently serves as Chair of the Biosimilars Canada industry association. He is also a passionate advocate for diversity, equity, and inclusion, regularly speaking on related topics. His commitment is reflected in Organon Canada receiving the highest gender-parity certification from Women in Governance.

Prior to this role, Michael supported Organon’s global CEO, Kevin Ali, as Chief of Staff. He was Managing Director for Merck in Finland and the Baltics and has held positions of increasing responsibility at global, regional, and local levels across nine countries.

Michael holds an MBA from Columbia Business School, New York, and a B.Sc. in Biochemistry from McGill University, Montreal.